(R)-2,2-Dimethyl-1-phenylpropan-1-amine hydrochloride, 95.0%, 250mg

2-(Quinolin-6-yl)propanoic acid, 95.0%, 100mg

E-Plan phase EPLPHi 10x/0.25 infinity corrected IOS objective. Working distance 5.95 mm

Dodecylboronic acid, 95.0%, 1g

2-Bromo-4,6-dimethylphenol, 95.0%, 10g

7-Bromoimidazo[1,2-a]pyridine-3-carbaldehyde, 95.0%, 100mg

4-Amino-3-iodobenzoic acid, 97.0%, 1g

S-(5-Bromo-2-formylphenyl) dimethylcarbamothioate, 95.0%, 250mg

(S)-2-Amino-3-methoxypropionic acid hydrochloride, 95.0%, 1g

1-Bromo-4-fluoro-2-nitro-5-(trifluoromethyl)benzene, 95.0%, 5g

6-(Thiophen-2-yl)pyridin-3-amine, 98%, 10g

(S)-1-(2,4-Dichlorophenyl)ethanamine, 95.0%, 250mg

2-((Tetrahydro-2H-pyran-4-yl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 5g